5:1 Reverse Stock Split Decision for Price Stabilization
-
5:1 reverse stock split (5 shares consolidated into 1, par value from 100 won to 500 won)
-
Total shares reduced from 77,549,006 to 15,509,801 (no capital reduction)
-
Purpose: stabilize stock price and enhance corporate value
-
Schedule: shareholder meeting 2026-07-06, effective 2026-07-22, trading halt 2026-07-20~08-10, new shares listing 2026-08-11
-
Fractional shares to be paid in cash based on closing price on listing day
-
Subject to shareholder approval at special meeting; details may change
KOSDAQ Filing Information
-
Filing: Stock Merger Decision
-
Company: GL Pharm Tech (204840)
-
Submission: GL Pharm Tech Corp.
-
Receipt: 05-19-2026
-
Under KRX KOSDAQ Market Division